- Report
- March 2026
- 406 Pages
Global
From €6288EUR$6,995USD£5,458GBP
- Report
- September 2025
- 325 Pages
Global
From €4314EUR$4,799USD£3,744GBP
- Report
- June 2025
- 456 Pages
Global
From €4449EUR$4,950USD£3,862GBP
- Report
- September 2025
- 147 Pages
Global
From €3595EUR$3,999USD£3,120GBP
- Report
- January 2026
- 150 Pages
Global
From €5348EUR$5,950USD£4,643GBP
- Report
- February 2026
- 311 Pages
Global
From €2247EUR$2,500USD£1,951GBP
- Report
- January 2026
- 191 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- May 2025
- 182 Pages
Global
From €4045EUR$4,500USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,503GBP
- Report
- March 2026
- 194 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- January 2026
- 160 Pages
Global
From €3018EUR$3,358USD£2,620GBP
€3551EUR$3,950USD£3,082GBP
- Report
- August 2025
- 186 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- August 2025
- 187 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- July 2025
- 150 Pages
Global
From €4359EUR$4,850USD£3,784GBP
- Report
- January 2026
- 192 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 182 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 185 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- August 2025
- 180 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- August 2025
- 182 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- July 2025
- 120 Pages
Global
From €5348EUR$5,950USD£4,643GBP

The Oligonucleotide Synthesis market is a segment of the biotechnology industry that focuses on the production of short, single-stranded DNA or RNA molecules. These molecules are used in a variety of applications, such as gene therapy, drug discovery, and diagnostics. Oligonucleotides are synthesized using a variety of techniques, including phosphoramidite chemistry, phosphorothioate chemistry, and solid-phase synthesis.
The Oligonucleotide Synthesis market is driven by the increasing demand for gene therapy and personalized medicine. Additionally, the development of new technologies, such as next-generation sequencing, has enabled the production of more complex oligonucleotides.
Some of the major players in the Oligonucleotide Synthesis market include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, Eurofins Scientific, and Bio-Synthesis. Show Less Read more